North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.
暂无分享,去创建一个
E. Perez | K. Rowland | A. Dueck | D. Northfelt | W. Lingle | T. Hobday | T. Fitch | D. Nikcevich | J. Allred | K. Sideras | R. Behrens